Table 4.
Secondary outcome measures at 12- to 14-month follow-up.a
| Characteristics | Intervention | Usual care | P value for difference crude | P value for difference adjustedb | |||||||||
|
|
Values | Change from baseline | Values | Change from baseline |
|
|
|||||||
| Risk factors | |||||||||||||
|
|
SBPc (mm Hg), mean (SD) | 126.9 (16.0) | −24.0 (31.1) | 126.5 (13.7) | −17.0 (28.3) | .22 | .09 | ||||||
|
|
DBPd (mm Hg), mean (SD) | 76.1 (10.9) | −12.6 (17.6) | 75.7 (9.2) | −11.3 (17.1) | .69 | .49 | ||||||
|
|
BMI (kg/m2), median (IQR) | 26.4 (23.6 to 30.1) | −0.3 (−1.3 to 1.0) | 27.1 (24.8 to 29.1) | −0.5 (−1.2 to 0.8) | .57 | .35e | ||||||
|
|
Total cholesterol (mmol/L), mean (SD) | 3.5 (0.9) | −1.3 (1.2) | 3.5 (0.8) | −1.5- (1.1) | .41 | .30 | ||||||
|
|
LDLf-cholesterol (mmol/L), mean (SD) | 2.1 (1.0) | −1.2 (1.1) | 2.0 (0.9) | −1.4 (1.0) | .20 | .21 | ||||||
|
|
HDLg-cholesterol (mmol/L), median (IQR) | 1.2 (1.0 to 1.5) | 0.1 (0.0 to 0.3) | 1.3 (1.0 to 1.5) | 0.1 (0.0 to 0.3) | .89 | .77 | ||||||
|
|
Triglycerides (mmol/L), median (IQR) | 1.0 (0.7 to 1.4) | −0.3 (−0.9 to 0.0) | 1.2 (0.8 to 1.5) | −0.3 (−0.8 to 0.8) | .48 | .98 | ||||||
|
|
Fasting plasma glucose (mmol/L), median (IQR) | 6.0 (5.6 to 6.7) | −1.5 (−3.3 to −0.2) | 6.0 (5.5 to 6.5) | −1.4 (−2.7 to 2.0) | .45 | .48 | ||||||
|
|
HbA1ch (mmol/mol), median (IQR) | 40.0 (36.0 to 43.0) | 1.0 (−0.2 to 3.0) | 38.0 (37.0 to 43.0) | 2.0 (−2.0 to 3.8) | .68 | .40 | ||||||
| Self-reported parameters, mean (SD) | |||||||||||||
|
|
Vegetable consumption | 2.1 (0.8) | 0.3 (1.0) | 2.0 (0.8) | 0.2 (0.7) | .67 | .77 | ||||||
|
|
Fruit consumption | 2.0 (0.8) | 0.3 (0.8) | 2.2 (0.8) | 0.3 (0.9) | .92 | .99 | ||||||
|
|
Fish consumption | 1.8 (1.1) | 0.6 (1.0) | 2.0 (0.9) | 0.7 (1.0) | .70 | .66 | ||||||
|
|
Consumption of sweets | 2.3 (0.8) | 0.4 (1.0) | 2.1 (0.9) | 0.3 (1.1) | .45 | .37 | ||||||
|
|
Healthy diet index | 8.2 (2.1) | 1.6 (2.2) | 8.2 (1.8) | 1.4 (2.2) | .69 | .45 | ||||||
aNumbers are presented as mean differences (SD), median differences (q1, q3), and P values. Crude and adjusted P values are shown for the differences in mean or median change (δ) between baseline and 12- to 14-month follow-up, comparing the intervention and usual care groups.
bAdjusted for gender, age, weight, previous heart disease, and smoking status at the time of the index event.
cSBP: systolic blood pressure.
dDBP: diastolic blood pressure.
eNot adjusted for weight.
fLDL: low-density lipoprotein.
gHDL: high-density lipoprotein.
hHbA1c: glycated hemoglobin A1c.